Position Statement on Genital Surgery in Individuals with Differences of Sex Development (DSD)/Intersex Traits

Read More

Child with Suspected Delayed Puberty

Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an…

Read More

Child with Suspected Sexual Precocity

Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an…

Read More

Child with Early Pubic Hair/Mature Body Odor

Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an…

Read More

Child with suspected Diabetes Insipidus

Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an…

Read More

Child with suspected Obesity and Metabolic Syndrome

Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an…

Read More

Infant with Ambiguous Genitalia

Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an…

Read More

Announcing the PES 2021 Virtual Annual Meeting

PES Going Virtual for 2021 We are pleased to announce the dates for the PES 2021 VIRTUAL Annual Meeting! April 30th- May 3rd, 2021 We are…

Read More

New Meds and Tech: Burosumab Twza (Crysvita – Ultragenyx Pharmaceuticals)

Prepared by Bhuvana Sunil, MD and Ambika Ashraf, MD Burosumab twza (Crysvita – Ultragenyx pharmaceuticals) is an injectable recombinant IgG1 human monoclonal antibody preparation neutralizing fibroblast…

Read More

New Meds and Tech: Semglee

Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc.…

Read More